// App-Quantinova.ai

BSH19‐PO‐142 : Fat Embolism Syndrome in Sickle Cell Disease: Current State and Future Prospects

Researchers

Presenter

  • D.A. Tsitsikas

Principal Investigators

  • J. May

  • R. Gangaraju

  • J. Abukar

  • R.J. Amos

  • M.B. Marques

Medical Centers

  • Haemoglobinopathy Service, Department of Haematology, Homerton University Hospital NHS Foundation Trust, London, United Kingdom

  • Division of Hematology/Oncology, Department of Medicine, Miami, FL

  • Division of Laboratory Medicine, Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Musculoskeletal

  • Blood/haematological Diseases

Disease

  • Fat embolism syndrome

  • Chronic kidney disease

  • Sickle cell anemia

  • Renal insufficiency

Biomarkers

  • Lactate dehydrogenase

  • Stearoyl-CoA desaturase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved